Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2019
Home
2019
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Minimum holding buy-back closed
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Minimum holding buy-back completed
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
FY2020 Growth Strategy Update May 2019
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid appoints Lyramid CEO to Accelerate Partnering
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Director’s Interest Notice
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid sets another sales record in Q4 FY2019
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
ASX Aware Query
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Investor Newsletter
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Notes to the Appendix 4C
Prev page
1
2
3
4
5
6
Next page
